{"entity":{"id":"nct03315026","kind":"trial","name":"Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis","aka":[],"tldr":"A phase 2 trial of Siltuximab in Multiple myeloma, run by Memorial Sloan Kettering Cancer Center, active and no longer recruiting.","summary":"Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis is a phase 2 interventional study registered as NCT03315026 by Memorial Sloan Kettering Cancer Center, with 30 participants planned, started 2017-12-14 and due to reach its primary completion in 2026-10. Interventions recorded: Siltuximab, The M.D. Anderson Symptom Inventory (MDASI). Conditions recorded: Multiple Myeloma, AL Amyloidosis.\n\nLinked to the drug Siltuximab because the registry names it among its interventions and Multiple myeloma among its conditions. Registry record only: no result has been read by an editor.","status":"active","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT03315026","url":"https://clinicaltrials.gov/study/NCT03315026"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["multiple-myeloma"],"sections":[],"technologies":[],"targets":[],"drugs":["siltuximab"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03315026","phase":"2","setting":"Phase II Study of Interleukin 6 Blockade With Siltuximab to Decrease Symptom Burden in Patients Age 60-75 Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma and AL Amyloidosis","sponsor":"Memorial Sloan Kettering Cancer Center","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03315026/","neighbours":{"cancer":[{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"}],"drug":[{"id":"siltuximab","kind":"drug","name":"Siltuximab","route":"/drugs/siltuximab/"}]}}